Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing

NCT03096717 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-03-19

No results posted yet for this study

Summary

Chronic intestinal inflammation produce dysplasia more frequently than the normal population. The therapies protect against these changes, but do not rule out dysplasia. It is not known the effect of different therapies protection.

Conditions

  • Dysplasia in IBD

Interventions

DIAGNOSTIC_TEST

colonoscopy and histology

colonic biopsies for detection of dysplasia

Sponsors & Collaborators

  • Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-05-30
Completion
2021-01-21

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096717 on ClinicalTrials.gov